Vascular Health and Risk Management
Volume 11, 2015 - Issue
Open access
69
Views
4
CrossRef citations to date
0
Altmetric
Review
Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease
Peter P Toth1 CGH Medical Center, Sterling IL, USA;2 Johns Hopkins University School of Medicine, Baltimore, MD, USACorrespondence[email protected]
Pages 9-23
|
Published online: 23 Dec 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.